Publication
Aripiprazole: a new option for people with schizophrenia
Mental health nurses have a crucial role in helping service users to select the pharmacological treatment that best supports their recovery goals. Jacquie White and colleagues weigh up the pros and cons of aripiprazole – the first third generation antipsychotic to be licensed in Europe and the US. While it can be helpful in treating schizophrenia, care needs to be taken when switching from another different antipsychotic medication
Jacquie White, Richard Gray, Martin Jones
Mental Health Practice, May 2007, RCNi
DOI: 10.7748/mhp2007.05.10.8.28.c4305